News
COR
242.99
-0.67%
-1.65
Weekly Report: what happened at COR last week (0318-0322)?
Weekly Report · 3d ago
4th Circuit sends West Virginia city's opioid case to state's top court
4th Circuit sends West Virginia city's opioid case to state's top court. The city and county of Huntington and Cabell County sued top drug distributors over the opioid crisis. A lower court rejected their case in 2022. The 4th Circuit sent the case to the state's highest court.
Reuters · 03/18 18:33
Cencora Inc.: Report of proposed sale of securities
Press release · 03/18 18:28
Weekly Report: what happened at COR last week (0311-0315)?
Weekly Report · 03/18 09:13
Judge trims US Justice Department lawsuit against Walmart over opioids
Judge trims US Justice Department lawsuit against Walmart over opioids Judge tosses claims over suspicious orders, 'red flags' Claims that company knowingly filled invalid prescriptions remain. The Justice Department accused Walmart of fueling the opioid epidemic. Walmart says the government's lawsuit is misguided and misapplies the law.
Reuters · 03/11 19:38
Weekly Report: what happened at COR last week (0304-0308)?
Weekly Report · 03/11 09:13
Weekly Report: what happened at COR last week (0226-0301)?
Weekly Report · 03/04 09:13
UPDATE 1-Cencora discloses data breach in cybersecurity incident
Drug distributor Cencora Inc discloses data breach in cybersecurity incident. Some of the data may have contained personal information, company says. The unauthorized activity was detected on Feb. 21, the company said. The company said the incident has had a material impact on its operations.
Reuters · 02/27 23:21
Cencora says hit by cyber attack on its information systems
Cencora says it has learned that data from its information systems had been exfiltrated. Some of the data may contain personal information, the drug distributor said in a filing. Cencora Inc says it was hit by a cyber attack on its information system.
Reuters · 02/27 22:53
Weekly Report: what happened at COR last week (0219-0223)?
Weekly Report · 02/26 09:15
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Home Depot, Palo Alto Networks, Wendys and Wendys among companies with revised targets. Discover Financial Services, Cardinal Health and other companies see analyst downgrades. Some analysts raised their target prices for the companies.
Reuters · 02/21 06:59
Weekly Report: what happened at COR last week (0212-0216)?
Weekly Report · 02/19 09:15
UPDATE 1-US FTC to probe shortage of drugs, chemotherapies in hospitals
US FTC to probe shortage of drugs, chemotherapies in hospitals. Federal Trade Commission to probe role played by some companies that distribute medicines to U.S. Hospitals. The FTC will examine if companies have misused their market power to push down prices of generic drugs.
Reuters · 02/14 15:07
Weekly Report: what happened at COR last week (0205-0209)?
Weekly Report · 02/12 09:14
Walgreens Boots pockets $992 mln after cutting Cencora stake for third time
Walgreens Boots pockets $992 mln after cutting Cencora stake for third time in just over six months. Walgreens has been grappling with waning demand for vaccines and testing. The drugstore chain has cut its stake in pharmaceutical distributor for the third time. The proceeds include around $942 million from shares sold.
Reuters · 02/08 00:29
U.S. RESEARCH ROUNDUP-Air Products and Chemicals , Hubspot and McDonald's
Wall Street analysts revise ratings and price targets on several U.S.-listed companies. Air Products and Chemicals, Hubspot and McDonald's among companies with revised targets. Hubspot raises its target price to $695 from $620; McDonald's cuts to from buy.
Reuters · 02/06 07:30
Weekly Report: what happened at COR last week (0129-0202)?
Weekly Report · 02/05 09:15
U.S. RESEARCH ROUNDUP-AT&T, Lennox International, Mastercard
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. AT&T, Lennox International, Mastercard and Boeing among companies with revised targets. Lennox raises target price to $414 from $392; Mastercard raises price target to $642 from $592.
Reuters · 02/01 07:05
Cencora Inc reports results for the quarter ended in December - Earnings Summary
Cencora Inc reports quarterly adjusted earnings of $3.28 per share for the quarter ended in December. Revenue rose 15% to $72.25 billion from a year ago. The company reported quarterly income of $601.5 million. Cencora shares had risen by 7.4% this quarter.
Reuters · 01/31 14:31
Cencora raises profit outlook due to robust demand for high-priced specialty drug
Cencora raises profit outlook due to robust demand for high-priced specialty drugs. Drug distributor also beat first-quarter profit and revenue estimates. Pennsylvania-headquartered company also beats first quarter revenue estimates, sending shares up 3%. Cencora has benefited from strong sales of specialty drugs and cheaper versions of biotech drugs.
Reuters · 01/31 13:14
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.